Literature DB >> 26029463

Optimal interval of surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: population level evidence in addition to controlled trial.

William Tzu-Liang Chen1, Tao-Wei Ke1, Yu-Min Liao1, Chia-Chin Li1, Chun-Ru Chien1.   

Abstract

Entities:  

Year:  2015        PMID： 26029463      PMCID： PMC4397256          DOI： 10.3978/j.issn.2078-6891.2014.106

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  10 in total

1.  Can it work? Does it work? Is it worth it? The testing of healthcareinterventions is evolving.

Authors:  B Haynes
Journal:  BMJ       Date:  1999-09-11

2.  3rd line Erlotinib for lung cancer in Asia may be as cost-effective as in the Western world.

Authors:  Ching-Chan Lin; Te-Chun Hsia; Chun-Ru Chien
Journal:  Lung Cancer       Date:  2012-04-13       Impact factor: 5.705

Review 3.  Interval to surgery after neoadjuvant treatment for colorectal cancer.

Authors:  Nir Wasserberg
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

4.  Use of Chinese medicine among survivors of nasopharyngeal carcinoma in Taiwan: a population-based study.

Authors:  Chun-Ru Chien; Shan-Yu Su; Lorenzo Cohen; Hsiang-Wen Lin; Richard Tsong Lee; Ya-Chen Tina Shih
Journal:  Integr Cancer Ther       Date:  2011-04-15       Impact factor: 3.279

5.  Consistently lower narcotics consumption after video-assisted thoracoscopic surgery for early stage non-small cell lung cancer when compared to open surgery: a one-year follow-up study.

Authors:  Hsin-Yuan Fang; Chih-Yi Chen; Yao-Ching Wang; Pin-Hui Wang; Shwn-Huey Shieh; Chun-Ru Chien
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-03       Impact factor: 4.191

6.  Effectiveness of intensity-modulated radiotherapy for lung cancer.

Authors:  T C Hsia; C Y Tu; H J Chen; C R Chien
Journal:  Clin Oncol (R Coll Radiol)       Date:  2013-04-11       Impact factor: 4.126

7.  Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.

Authors:  D A M Sloothaak; D E Geijsen; N J van Leersum; C J A Punt; C J Buskens; W A Bemelman; P J Tanis
Journal:  Br J Surg       Date:  2013-03-27       Impact factor: 6.939

8.  Effectiveness of neoadjuvant concurrent chemoradiotherapy versus up-front proctectomy in clinical stage II-III rectal cancer: A population-based study.

Authors:  Tao-Wei Ke; Yu-Min Liao; Hua-Che Chiang; Sheng-Chi Chang; Pin-Hui Wang; Yi-Ya Chen; William Tzu-Liang Chen; Chun-Ru Chien
Journal:  Asia Pac J Clin Oncol       Date:  2014-01-24       Impact factor: 2.601

9.  Use of personalized decision analysis in decision making for Palliative vs. surgical management of the oldest-old patients with localized skin cancer in a culturally sensitive environment: a case study of a 96-year-old male Taiwanese patient.

Authors:  Chun-Ru Chien; Ya-Chen Tina Shih
Journal:  J Pain Symptom Manage       Date:  2012-08-20       Impact factor: 3.612

10.  Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study.

Authors:  Sezer Saglam; Dursun Bugra; Esra K Saglam; Oktar Asoglu; Emre Balik; Sumer Yamaner; Mert Basaran; Ethem N Oral; Ahmet Kizir; Yersu Kapran; Mine Gulluoglu; Burak Sakar; Turker Bulut
Journal:  J Gastrointest Oncol       Date:  2014-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.